Skip to Content

Personalised Dosing – Patient-centered Dupilumab Dosing Regimen in AD

In this MEDtalk, MD, and Ph.D., Lotte S. Spekhorst presents her study presented at this year’s EADV, investigating different dupilumab dosing regimens in patients with controlled atopic dermatitis (AD). Results suggest a successful dose reduction regimen related to the serum drug levels and serum biomarkers. See original publication here.

Få tilgang til artikkelen

Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.

Back to top